BackEntrada Therapeutics Overview

Entrada Therapeutics Total Revenue

Revenue analysis for TRDA.

Quarterly Revenue

$875000.00
95.74% YoY

As of Mar 2026

Annual Revenue (TTM)

$5.74M
96.67% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading